XXII

22nd Century Group, Inc. [XXII] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

XXII Stock Summary

Top 10 Correlated ETFs

XXII

Top 10 Correlated Stocks

XXII

In the News

XXII Financial details

Company Rating
-
Market Cap
5.85M
Income
-139.6M
Revenue
60.62M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
64
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-0.03
Forward P/E
-
PEG
0
P/S
0.11
P/B
0.26
P/C
-
P/FCF
-0.11
Quick Ratio
0.23
Current Ratio
1.02
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-113.51
EPS next Y
-
EPS next Q
-
EPS this Y
-90.26%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
18.71%
Revenue last 5Y
4.51%
Revenue Q/Q
-6.53%
EPS Q/Q
-76.04%
-
-
-
-
SMA20
-42.56%
SMA50
-76.57%
SMA100
-92.01%
Inst Own
-
Inst Trans
-
ROA
-213%
ROE
-207%
ROC
-4.44%
Gross Margin
-27%
Oper. Margin
-150%
Profit Margin
-188%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.45-180.96
52W High
-99.51%
52W Low
-10.99%
RSI
23.39
Rel Volume
0.51
Avg Volume
1.45M
Volume
742.25K
Perf Week
-31.53%
Perf Month
-53.64%
Perf Quarter
-93.5%
Perf Half Y
-96.37%
-
-
-
-
Beta
1.486
-
-
Volatility
0.08%, 0.37%
Prev Close
-6.59%
Price
0.8901
Change
-10.09%

Something similar

Top by Market Cap
LLY.SW
GOOGL
ABEC.DE
MSF.DE
NVDA
Top Correlated ETFs
HMMJ.TO
YOLO
SC0P.DE
EXV5.DE
ALYU.L
Top Correlated Stocks
STKL
SOY.TO
DND.TO
NKE
XRX
Similar Market Cap
MARAS.HE
WBII
MIMO
MAYZ
DBMM

Company Profile

Consumer Defensive Tobacco
  • Volume Average 1.45M
  • Market Capitalization 5.85M
  • Employee 64
  • CEO Mr. Lawrence D. Firestone
  • Headquarters Buffalo,NY,US
  • IPO Date 2011-01-26
  • Website https://www.xxiicentury.com

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.